Amnon Peled

Insider Reports History

Location
Tel Aviv, Israel
Signature
/s/ Mirit Horenshtein Hadar, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amnon Peled:

Company Role Class Num Shares Value Price $ Report Date Ownership
Silexion Therapeutics Corp Director Stock Option (right to buy Ordinary Shares) 8,904 $21,725 $2.44 20 Feb 2026 Direct
Silexion Therapeutics Corp Director Ordinary Shares 8,237 $20,098 $2.44 20 Feb 2026 Direct

Insider Reports Filed by Amnon Peled

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLXN Silexion Therapeutics Corp 20 Feb 2026 2 $0 4 Director 23 Feb 2026, 16:11
SLXN Silexion Therapeutics Corp 09 Feb 2025 2 $0 4 Director 31 Dec 2025, 13:00
SLXN Silexion Therapeutics Corp 10 Dec 2024 0 $0 3 Director 18 Dec 2024, 06:00